Side-by-side guides for people comparing legal psilocybin access, ketamine clinics, MDMA-assisted therapy research, and treatment-fit questions.
Use this hub when the core question is comparative: which therapy model fits a condition, how legal access differs by state, what a session costs, or how the evidence compares across psilocybin, ketamine, and MDMA-assisted therapy.
Focused comparison for depression care: mechanism, session structure, legal access, durability, and cost.
Read comparisonDecision guide for legal access: service centers, healing centers, facilitator rules, costs, and travel.
Read comparisonThree-way therapy comparison by condition fit, evidence, risks, legal status, and access.
Read comparisonStart with condition fit: depression, PTSD, treatment-resistant depression, or legal access. Then compare trial quality, durability, risks, and cost.
Review conditionsPsilocybin, ketamine, and MDMA differ in session length, preparation, integration, prescribing model, and medical screening requirements.
See psilocybin protocolState-regulated psilocybin programs, ketamine clinics, and clinical trials have different legal, medical, and financial tradeoffs.
Check legal status